Medannex has been granted an award for ‘Innovation in Autoimmune Disease Treatment’ at Corporate LiveWire’s Healthcare & Life Sciences Awards 2018. This recognition is a result of Medannex’s innovative development programme for a novel antibody to a unique target, that has great potential as a new treatment for various autoimmune diseases.